Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Palmer

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Genes, Chromosomes & Cancer|January 1, 1994
Trisomy 7: a potential cytogenetic marker of human prostate cancer progressionM G Bandyk, L Zhao, P Troncoso, et al.
Federation Proceedings|August 1, 1982
Role of insulin-stimulated protein phosphorylation in insulin actionJ Avruch, M C Alexander, J L Palmer, et al.
Journal of the National Cancer Institute|October 20, 1993
p53 protein accumulation and gene mutation in the progression of human prostate carcinomaN M Navone, P Troncoso, L L Pisters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphomaA Younes, H A Preti, F B Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
CD30 ligand in lymphoma patients with CD30+ tumorsA Younes, U Consoli, V Snell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage IIL M Fuller, N Q Mirza, J L Palmer, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
Urologic Oncology|January 13, 2011
Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulationsH E Zhau, L S Zhao, L W Chung, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Genes, Chromosomes & Cancer|January 1, 1994
Trisomy 7: a potential cytogenetic marker of human prostate cancer progressionM G Bandyk, L Zhao, P Troncoso, et al.
Federation Proceedings|August 1, 1982
Role of insulin-stimulated protein phosphorylation in insulin actionJ Avruch, M C Alexander, J L Palmer, et al.
Journal of the National Cancer Institute|October 20, 1993
p53 protein accumulation and gene mutation in the progression of human prostate carcinomaN M Navone, P Troncoso, L L Pisters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphomaA Younes, H A Preti, F B Hagemeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
CD30 ligand in lymphoma patients with CD30+ tumorsA Younes, U Consoli, V Snell, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1995
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiationL M Fuller, M J Krasin, W S Velasquez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphomaI F Khouri, J Romaguera, H Kantarjian, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage IIL M Fuller, N Q Mirza, J L Palmer, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
Urologic Oncology|January 13, 2011
Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulationsH E Zhau, L S Zhao, L W Chung, et al.
Pageof 7